Sign up to get free evidence-based articles, exclusive discounts, and insights from industry-leaders.
Email could not be subscribed.
Thank you for signing up!
presented by Lisa Milliken, MA, CCC-SLP, FNAP, CDP, RAC-CT
Financial: Lisa Milliken receives compensation from MedBridge for this course.
Nonfinancial: Lisa Milliken has no competing nonfinancial interests or relationships with regard to the content presented in this course.
Satisfactory completion requirements: All disciplines must complete learning assessments to be awarded credit, no minimum score required unless otherwise specified within the course.
MedBridge is committed to accessibility for all of our subscribers. If you are in need of a disability-related accommodation, please contact [email protected]. We will process requests for reasonable accommodation and will provide reasonable accommodations where appropriate, in a prompt and efficient manner.
Lisa Milliken, MA, CCC-SLP, FNAP, CDP, RAC-CT
Lisa Milliken received her BA from Louisiana Tech University and her MA from the University of Memphis in audiology and speech-language pathology. She has since served adults and geriatrics as a clinician, manager, vice president, consultant, compliance manager, and education director and is passionate about mentoring healthcare professionals across the country. She currently provides continuing…
Read full bioEmail could not be subscribed.
Thank you for signing up!
Thank you!
1. The Big Picture of Polypharmacy and the Body’s Response to Medications
This chapter will briefly discuss the risks with polypharmacy, including the current evidence related to cognitive and physical decline and other significant precautions. Then the role of increased adverse effects with aging will be shared, to include a summary of the changes in pharmacokinetics and pharmacodynamics, such as those related to changes in body composition, hepatic function, and renal function.
2. Key Points to Understanding Medications That Act on the Central Nervous System
This section provides an overview of the effects of multiple drug classes, including antihistamines and multiple classes of medications that act on the central nervous system (CNS), such as antidepressants, antianxiety medications, antipsychotics, benzodiazepines, antiepileptics, hypnotics, opioids, and sedatives. Given the potential adverse effects and drug–drug interactions of these medications, a discussion of monitoring systems, precautions, and a case study will be included.
3. Key Points to Understanding Common Antibiotics, Analgesics, and Bronchodilators
This section provides an overview of the effects of three drug classes: antibiotics, analgesics, and bronchodilators. Precautions, monitoring systems, and a case study will be reviewed to facilitate learning.
4. Key Points to Understanding Proton Pump Inhibitors and Statins
This section provides an overview of the effects of hormones, proton pump inhibitors, and statins. Drug–drug interactions, prescribing cascades, and precautions will be reviewed to recommend the needed monitoring systems and ongoing need for medication review.
5. Key Points to Understanding Antidiabetics and Antihypertensives
This section provides an overview of the effects of antidiabetics and antihypertensives, including the significant risk of drug–drug interactions and precautions needed with patients taking medications from either or both of these drug classes. Herbal supplements will also be discussed, including their risks when taken with the abovementioned drug classes as well as with other prescribed medications.
6. Steps to Direct Optimal Clinical Outcomes
This section will include recent evidence for medication reconciliation and deprescribing practices to prevent risks and improve patient outcomes. Collaboration between the interprofessional team members will be stressed to optimize their respective plans of care, as will the recommended education practices to use with the patient and caregiver for the best clinical outcomes.
More Courses in this Series
Email could not be subscribed.
Thank you for signing up!
Email could not be subscribed.
Thank you for signing up!
For groups of 5 or more, request a demo to learn about our solution and pricing for your organization. For other questions or support, visit our contact page.
Contact sales to learn about our solution and pricing for your organization. For other questions or support, visit our contact page.